RETRACTION: Melatonin Attenuates Apoptotic Liver Damage in Fulminant Hepatic Failure Induced by the Rabbit Hemorrhagic Disease Virus(J Pineal Res, (2011), 50, (38-45), 10.1111/j.1600-079X.2010.00807.x);Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus

Journal of Pineal Research

Volumn 50, Issue 1, 2011, Pages 38-45

  Tuñõn, María J ^a,b   Miguel, Beatriz San ^a,b   Crespo, Irene ^a,b   Jorquera, Francisco ^b,c   Santamaría, Eva ^b,c   Alvarez, Marcelino ^a   Prieto, Jesãs ^b,d   González Gallego, Javier ^a,b  

^a UNIVERSITY OF LEÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital of Leõ   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

apoptosis; fulminant hepatic failure; melatonin

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; FLICE INHIBITORY PROTEIN; GLUTATHIONE; JANUS KINASE; MELATONIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; FULMITANT LIVER FAILURE; LAGOVIRUS; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RABBIT; VIRUS HEMAGGLUTINATION;

EID: 78650084126     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12976     Document Type: Erratum

References (43)

1. Pretet JL, Pelletier L, Bernard B, et al. Apoptosis participates to liver damage in HSV-induced fulminant hepatitis. Apoptosis 2003; 8: 655-663.
2. Mauriz JL, Tuñõn MJ, González-Gallego J,. Apoptotic signalling pathways as a target for treatment of liver diseases. Mini Rev Med Chem 2008; 8: 1485-1493.
3. Schuchmann M, Galle PR,. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 2001; 13: 785-790.
4. Eichorst ST,. Modulation of apoptosis as a target for liver disease. Expert Opin Ther Targets 2005; 9: 83-89.
5. Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347-351.
6. Zender L, Hutker S, Liedtke C, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 2003; 100: 7797-7802.
7. Kim SH, Kim YS, Kang SS, Bae K, Hung TM, Sung L,. Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Pharmacol Sci 2008; 106: 225-233.
8. Wu YL, Lian LH, Jiang YZ, et al. Hepatoprotective effects of salidroside fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Pharm Pharmacol 2009; 61: 1375-1382.
9. Miyasou T, Kwon AH, Tsuji K, et al. Edaravone prevents Fas-induced fulminant hepatic failure in mice by regulating mitochondrial Bcl-xL and Bax. Shock 2008; 30: 212-216.
10. Korkmaz A, Reiter RJ, Topal T, et al. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009; 15: 43-50.
11. Sainz RM, Mayo JC, Rodriguez C, et al. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60: 1407-1426.
12. Bejarano I, Redondo PC, Espino J, et al. Melatonin induces mitocondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46: 392-400.
13. Samantaray S, Das A, Thakore NP, et al. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 2009; 47: 134-143.
14. Rubio S, Etevez F, Cabrera J, et al. Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid H-60 cells. J Pineal Res 2007; 42: 131-138.
15. Martín-Renedo J, Mauriz JL, Jorquera F, et al. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008; 45: 532-540.
16. Kim SH, Lee SM,. Cytoprotective effect of melatonin against necrosis and apoptosis induced by ischemia-reperfusion injury in rat liver. J Pineal Res 2008; 44: 165-171.
17. Molpeceres V, Mauriz JL, García-Mediavilla V, et al. Melatonin is able to reduce the apoptotic liver changes induced by aging via inhibition of the intrinsic pathway of apoptosis. J Gerontol Biol Sci 2007; 62A: 687-695.
18. Hu S, Yin S, Jiang X, et al. Melatonin protects against alcoholic liver injury by attenuating oxidatives stress, inflammation response, and apoptosis. Eur J Pharmacol 2009; 616: 287-292.
19. Wang H, Xu DX, Lv JW, et al. Melatonin attenuates lypopolysaccharide (LPS)-induced liver damage in D-galactosamine-sensitized mice. Toxicology 2007; 237: 49-57. (Pubitemid 47031404)
20. Tuñõn MJ, Sanchez-Campos S, Garcia-Ferreras J, et al. Rabbit hemorrhagic viral disease: characterization of a new animal model of fulminant liver failure. J Lab Clin Med 2003; 141: 272-278.
21. García-Lastra R, San Miguel B, Crespo I, et al. MAP kinases, NF-kappaB, AP-1 and STATs signaling pathways in a viral model of fulminant hepatic failure. Vet Res 2010; 41: 2.
22. Tuñõn MJ, ÃLvarez M, Culebras JM, et al. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 2009; 15: 3086-3098.
23. San Miguel B, Alvarez M, Culebras JM, et al. N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure. Apoptosis 2006; 11: 1945-1957.
24. Mauriz JL, Gonzalez F, Jorquera F, et al. Caspase inhibition does not protect against liver damage in hemorrhagic shock. Shock 2003; 19: 33-37.
25. Moreira A, Fraga C, Alonso M, et al. Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats. Biochem Pharmacol 2004; 68: 1939-1946.
26. García-Mediavilla MV, Sánchez-Campos S, González-Pérez P, et al. Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J Hepatol 2005; 43: 603-613.
27. Hissin PJ, Hilf R,. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-226.
28. Willis ED,. Evaluation of lipid peroxidation in lipids and biological membranes. In: Biochemical Toxicology: a Practical Approach, Snell K, Mullock B, eds., IRL Press, Oxford, 1985; pp. 407-420.
29. Liang R, Nickkholg A, Hoffmann K, et al. Melatonin protects from hepatic reperfusion injury through inhibition of IKK and JNK pathways and modification of cell proliferation. J Pineal Res 2009; 46: 8-14.
30. Tahan V, Atug O, Akin H, et al. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats. J Pineal Res 2009; 46: 401-407.
31. Crespo I, San Miguel B, Laliena A, et al. Melatonin prevents decreased activity of antioxidant enzymes and activates nuclear erythroid 2-related factor 2 signaling in an animal model of fulminant hepatic failure of viral origin. J Pineal Res 2010; 49: 193-200.
32. Mauriz JL, Matilla B, Culebras JM, et al. Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat. Free Radic Biol Med 2001; 31: 1236-1244.
33. Fabregat I, Roncero C, Fernandez M,. Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int 2007; 27: 1551-1562.
34. Radogna F, Cristofanon S, Paternoster L, et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008; 44: 316-325.
35. Maity P, Bindu S, Dey S, et al. Melatonin reduces indomethacin-induced gastric mucosal cell apoptosis by preventing mitochondrial oxidatives stress and the activation of mitochondrial pathway of apoptosis. J Pineal Res 2009; 46: 314-323.
36. Cowling V, Donward J,. Caspase-6 is the direct activator of caspase-8 in the cythochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ 2002; 9: 1046-1056.
37. Slee EA, Harte MT, Kluck RM, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-dependent-manner. J Cell Biol 1999; 144: 281-292.
38. Takai S, Nagaki M, Imao M, et al. Intrinsic resistance to TNF-α-induced hepatocyte apoptosis in ICR mice correlates with expression of a short form of c-FLIP. Lab Invest 2007; 87: 572-581.
39. Matsumaru K, Ji C, Kaplowitz N,. Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology 2003; 37: 1425-1434.
40. Harhaji L, Isakovic A, Vucicevic L, et al. Modulation of tumour necrosis factor-mediated cell death by fullerenes. Pharmacol Res 2008; 25: 1365-1376.
41. Lu JW, Wang H, Yan-Li J, et al. Differential effects of pyrrolidine dithiocarbamate on TNF-α-mediated liver injury in two different models of fulminant hepatitis. J Hepatol 2008; 48: 442-452.
42. González-Rodríguez A, Alba J, Zimmerman V, et al. SK61 deficiency protects against apoptosis in hepatocytes. Hepatology 2009; 50: 216-229.
43. L turnover. Cell 2006; 124: 601-613.